These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24257106)

  • 1. [The issue of low doses in radiation therapy and impact on radiation-induced secondary malignancies].
    Chargari C; Cosset JM
    Bull Cancer; 2013 Dec; 100(12):1333-42. PubMed ID: 24257106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [IMRT combined to IGRT: increase of the irradiated volume. Consequences?].
    Lisbona A; Averbeck D; Supiot S; Delpon G; Ali D; Vinas F; Diana C; Murariu C; Lagrange JL
    Cancer Radiother; 2010 Oct; 14(6-7):563-70. PubMed ID: 20729117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation-induced cancers from modern radiotherapy techniques: intensity-modulated radiotherapy versus proton therapy.
    Yoon M; Ahn SH; Kim J; Shin DH; Park SY; Lee SB; Shin KH; Cho KH
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1477-85. PubMed ID: 19879701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of radiation-induced second cancers in the high to medium dose region: a comparison between passive and scanned proton therapy, IMRT and VMAT for pediatric patients with brain tumors.
    Moteabbed M; Yock TI; Paganetti H
    Phys Med Biol; 2014 Jun; 59(12):2883-99. PubMed ID: 24828559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity-modulated radiation therapy, protons, and the risk of second cancers.
    Hall EJ
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):1-7. PubMed ID: 16618572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure Risks Among Children Undergoing Radiation Therapy: Considerations in the Era of Image Guided Radiation Therapy.
    Hess CB; Thompson HM; Benedict SH; Seibert JA; Wong K; Vaughan AT; Chen AM
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):978-92. PubMed ID: 27026304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of intensity-modulated radiotherapy on radiation-induced second malignancies.
    Ruben JD; Davis S; Evans C; Jones P; Gagliardi F; Haynes M; Hunter A
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1530-6. PubMed ID: 18207670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of second cancers in the era of modern radiation therapy: does the risk/benefit analysis overcome theoretical models?
    Chargari C; Goodman KA; Diallo I; Guy JB; Rancoule C; Cosset JM; Deutsch E; Magne N
    Cancer Metastasis Rev; 2016 Jun; 35(2):277-88. PubMed ID: 26970966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation field.
    Paganetti H; Athar BS; Moteabbed M; A Adams J; Schneider U; Yock TI
    Phys Med Biol; 2012 Oct; 57(19):6047-61. PubMed ID: 22968191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of organ-specific peripheral doses after 2-dimensional, 3-dimensional and hybrid intensity modulated radiation therapy for breast cancer based on Monte Carlo and convolution/superposition algorithms: implications for secondary cancer risk assessment.
    Joosten A; Matzinger O; Jeanneret-Sozzi W; Bochud F; Moeckli R
    Radiother Oncol; 2013 Jan; 106(1):33-41. PubMed ID: 23351844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doses to carotid arteries after modern radiation therapy for Hodgkin lymphoma: is stroke still a late effect of treatment?
    Maraldo MV; Brodin P; Aznar MC; Vogelius IR; Munck af Rosenschöld P; Petersen PM; Specht L
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):297-303. PubMed ID: 23910709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer.
    Fontenot JD; Lee AK; Newhauser WD
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):616-22. PubMed ID: 19427561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of critical structure dose and toxicity risks in patients with low grade gliomas treated with IMRT versus proton radiation therapy.
    Dennis ER; Bussiere MR; Niemierko A; Lu MW; Fullerton BC; Loeffler JS; Shih HA
    Technol Cancer Res Treat; 2013 Feb; 12(1):1-9. PubMed ID: 22775339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Which intensity modulated radiation therapy? From "step and shoot" to volumetric modulated arc therapy, point of view of the radiation oncologist].
    Vieillot S; Fenoglietto P; Moscardo CL; Aillères N; Lemanski C; Dubois JB; Azria D
    Cancer Radiother; 2010 Oct; 14(6-7):550-3. PubMed ID: 20724189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of second brain tumors related to cranial irradiation.
    Marta GN; Murphy E; Chao S; Yu JS; Suh JH
    Expert Rev Anticancer Ther; 2015 Mar; 15(3):295-304. PubMed ID: 25482749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma.
    Hodgson DC; Koh ES; Tran TH; Heydarian M; Tsang R; Pintilie M; Xu T; Huang L; Sachs RK; Brenner DJ
    Cancer; 2007 Dec; 110(11):2576-86. PubMed ID: 17941006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical evaluation of secondary cancer risk models applied to Monte Carlo dose distributions of 2-dimensional, 3-dimensional conformal and hybrid intensity-modulated radiation therapy for breast cancer.
    Joosten A; Bochud F; Moeckli R
    Phys Med Biol; 2014 Aug; 59(16):4697-722. PubMed ID: 25082795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy-induced secondary cancer risk for breast cancer: 3D conformal therapy versus IMRT versus VMAT.
    Lee B; Lee S; Sung J; Yoon M
    J Radiol Prot; 2014 Jun; 34(2):325-31. PubMed ID: 24705154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of radio-induced cancers].
    Cosset JM; Chargari C; Demoor C; Giraud P; Helfre S; Mornex F; Mazal A
    Cancer Radiother; 2016 Sep; 20 Suppl():S61-8. PubMed ID: 27523416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.